Join our exclusive Tech Talks featuring a series of cutting-edge presentations on demonstrating technical excellence in process development and manufacturing for antibody-drug conjugates (ADCs) and bioconjugates. As an established CDMO, we will provide valuable insights on successfully scaling up from PAD to manufacturing, leveraging an integrated linker-payload supply chain, and implementing Process Analytical Technology (PAT). These innovative approaches and technologies are essential for ADC developers to bring novel therapies to patients. Register now to gain access to expert knowledge that will drive innovation and accelerate your ADC development and manufacturing program.
In these Tech Talks, you will gain insights from industry experts on:
- Enhancing conjugation processes and time efficiency through the outsourcing of drug-linker supplies and conjugation to a single CDMO
- Successfully achieving a seamless scale-up and reliable transfer from pilot batch to GMP manufacturing
- Advances in the application of process analytical technology (PAT) in bioconjugation processes
Speakers
Tom Hunter
Merck
Associate Director, Process Development
Tom is currently the head of the process development group in Madison, WI. While working for our company for over 15 years, he has developed a wide variety of early- and late-stage projects, acting as the lead development scientist for two commercial linker-payload projects. Prior, Tom was employed at Schering-Plough Pharmaceuticals. He obtained his Ph.D. in organic chemistry from the University of Minnesota and completed a post-doctoral fellowship at Stanford.
Lisa McDermott
Merck
Director Process and Analytical Development
Lisa joined Merck in January 2010 as an analytical project lead, responsible for ADCs. She brings with her more than 25 years of experience in both organic synthesis and analytical sciences and has had the opportunity to contribute to many projects ranging from discovery to full development, but none has been as exciting as the emergence of ADCs. She also has an extensive chromatography background with experience in integrated LC/MS screening systems.
Gary Conway
Merck
Principal Production Scientist
During his 8 years as principal production scientist at Merck, Gary has been actively involved in the transfer, scale-up, validation and manufacture of numerous projects of clinical and commercial bioconjugations . He has 25+ years of experience in upstream and downstream manufacturing and management, all in cGMP regulated environments.
Kim Nguyen
Merck
Senior Scientist, ADC and LNP Template Innovation
Kim is a senior scientist at the ADC & LNP template innovation department. During her 8 years at Merck, she has been focusing on analytical method development and optimization. She has 10+ years of experience in analytical R&D, project management, and technology transfer to GMP manufacturing. Kim received her Ph.D. from Washington University in St. Louis.
Giuseppe Camporeale
Merck
Field Marketing Manager
In his current role, Giuseppe supports our business development in Europe, Middle-East and Africa, advising our customers around quality, regulatory compliance, and technologies for the pharmaceutical manufacturing of high-potent APIs and bioconjugates. He joined our company 8 years ago, working in the technical service and field marketing teams in our process solutions and life science services departments. Giuseppe holds a master's degree in biotechnology and a Ph.D. in chemistry from the University of Bari (Italy).
Pharma and biopharma manufacturing
- Pharma and biopharma manufacturing
Duration:1h 30min
語言:English
會話 1:提出 October 24, 2024
若要繼續閱讀，請登入或建立帳戶。
還沒有帳戶？